DORIBAX

This brand name is authorized in Estonia, Singapore, South Africa

Active ingredients

The drug DORIBAX contains one active pharmaceutical ingredient (API):

1 Doripenem UNII 4B035T6NKT - DORIPENEM MONOHYDRATE

Doripenem is a synthetic carbapenem antibacterial agent. Doripenem exerts its bactericidal activity by inhibiting bacterial cell wall biosynthesis. Doripenem inactivates multiple essential penicillin-binding proteins (PBPs) resulting in inhibition of cell wall synthesis with subsequent cell death. Read about Doripenem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Doribax 500mg powder for solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
DORIBAX Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DH04	Doripenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1363676, 1462913
Country: SG	Health Sciences Authority	Identifier(s): 13613P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/20.1.1/0647